SANA BIOTECHNOLOGY Trademark

Trademark Overview

On Thursday, November 29, 2018, a trademark application was filed for SANA BIOTECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the SANA BIOTECHNOLOGY trademark a serial number of 88211007. The federal status of this trademark filing is REGISTERED as of Tuesday, February 21, 2023. This trademark is owned by Sana Biotechnology, Inc.. The SANA BIOTECHNOLOGY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific laboratory services, namely, blood processing services, namely, processing blood to be used in cell therapies for medical or clinical purposes; blood processing services, namely, processing blood to be used in gene therapies for medical or clinical purposes; scientific research and development; pharmaceutical research and development
sana biotechnology

General Information

Serial Number88211007
Word MarkSANA BIOTECHNOLOGY
Filing DateThursday, November 29, 2018
Status700 - REGISTERED
Status DateTuesday, February 21, 2023
Registration Number6986662
Registration DateTuesday, February 21, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 29, 2019

Trademark Statements

Description of MarkThe mark consists of the word "Sana" in a large font above the word "Biotechnology" in a smaller font with a circular design element to the right side of the words that is partially bisected by a line which is connected to a smaller circle within the lower left section of the larger circle.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording "SANA" has no meaning in a foreign language.
Disclaimer with Predetermined Text"BIOTECHNOLOGY"
Goods and ServicesScientific laboratory services, namely, blood processing services, namely, processing blood to be used in cell therapies for medical or clinical purposes; blood processing services, namely, processing blood to be used in gene therapies for medical or clinical purposes; scientific research and development; pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 17, 2018
Primary Code042
First Use Anywhere DateFriday, August 26, 2022
First Use In Commerce DateFriday, August 26, 2022

Trademark Owner History

Party NameSana Biotechnology, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102
Party NameSana Biotechnology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102
Party NameSana Biotechnology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102

Trademark Events

Event DateEvent Description
Tuesday, February 27, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 27, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 27, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 21, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 21, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, January 18, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 17, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 4, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 4, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 4, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 27, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, December 23, 2022USE AMENDMENT FILED
Friday, December 23, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, July 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 11, 2022SOU EXTENSION 5 GRANTED
Friday, June 24, 2022SOU EXTENSION 5 FILED
Thursday, July 7, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 24, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 20, 2021SOU EXTENSION 4 GRANTED
Monday, December 20, 2021SOU EXTENSION 4 FILED
Monday, December 20, 2021SOU TEAS EXTENSION RECEIVED
Friday, May 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 5, 2021SOU EXTENSION 3 GRANTED
Wednesday, May 5, 2021SOU EXTENSION 3 FILED
Wednesday, May 5, 2021SOU TEAS EXTENSION RECEIVED
Saturday, October 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 22, 2020SOU EXTENSION 2 GRANTED
Thursday, October 22, 2020SOU EXTENSION 2 FILED
Thursday, October 22, 2020SOU TEAS EXTENSION RECEIVED
Friday, June 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 17, 2020SOU EXTENSION 1 GRANTED
Wednesday, June 17, 2020SOU EXTENSION 1 FILED
Wednesday, June 17, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, December 24, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 29, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 29, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 9, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 19, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 5, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 5, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 5, 2019ASSIGNED TO LIE
Thursday, August 29, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 5, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 5, 2019NON-FINAL ACTION E-MAILED
Tuesday, March 5, 2019NON-FINAL ACTION WRITTEN
Thursday, February 28, 2019ASSIGNED TO EXAMINER
Tuesday, December 18, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, December 17, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 3, 2018NEW APPLICATION ENTERED

Related Keywords

biotechnology sana processing blood namely services clinical purposes development medical used research